Molecular Determinants of Atherosclerotic Plaque Vulnerability a

The devastating clinical consequences of atherosclerosis usually result from thrombotic complications of lesions. In the coronary circulation, a transient or subtotal thrombus may provoke unstable angina pectoris. A sustained, occlusive coronary thrombus often produces acute myocardial infarction. Data from recent anatomical and angiographic studies have provided considerable insight into the pathobiology of these clinical manifestations of coronary artery disease. We now recognize that many coronary thrombi result from a physical disruption of an atherosclerotic plaque. 1 ~ 3 In some cases, a superficial abrasion of the endothelial surface overlying an atherosclerotic plaque occurs. This type of desquamative injury uncovers constituents of the basement membrane including thrombogenic forms of collagen, inciting the formation of a clot. Another common type of disruption of atherosclerotic plaques results from an actual fracture or tear of the fibrous cap that typically overlies the lipid-rich core of advanced atherosclerotic plaques. Indeed, retrospective analyses of atherosclerotic plaques that have caused the demise of a patient frequently show such ruptures of the plaque's fibrous cap. Pathologic studies have revealed certain characteristics shared by plaques that have ruptured and provoked coronary thrombosis (TABLE 1 ) : ~ ~ Rupture-prone plaques tend to have thin fibrous caps, the structure that overlies the thrombogenic lipid-rich core of the lesion, separating it from the blood. Such plaques commonly contain large accumulations of lipid and many macrophage-derived foam cells. Regions of plaques that have ruptured characteristically contain foci of inflammation, as revealed by the presence of T lymphocytes and macrophages. Cells in the portions of these plaques often bear markers of inflammatory activation, such as the histocompatibility antigen HLA-DR. Interestingly, the region of the plaque at the site of rupture often has relatively few vascular smooth muscle cells. This finding contrasts with the widely held belief that this cell type predominates in the atherosclerotic intima.

[1]  L. Matrisian Matrix Metalloproteinase Gene Expression a , 1994, Annals of the New York Academy of Sciences.

[2]  P. Libby,et al.  Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  R D Kamm,et al.  Mechanical properties of model atherosclerotic lesion lipid pools. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[4]  J. Muller,et al.  Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier. , 1994, Journal of the American College of Cardiology.

[5]  H. Hodis,et al.  George Lyman Duff Memorial Lecture. Arterial imaging and atherosclerosis reversal. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[6]  M J Davies,et al.  Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. , 1985, British heart journal.

[7]  P. Libby,et al.  Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[8]  V. Fuster,et al.  Coronary plaque disruption. , 1995, Circulation.

[9]  P. Libby,et al.  Apoptosis of Vascular Smooth Muscle Cells Induced by In Vitro Stimulation With Interferon-γ, Tumor Necrosis Factor–α, and Interleukin-1β , 1996 .

[10]  L. Gibson,et al.  Static circumferential tangential modulus of human atherosclerotic tissue. , 1994, Journal of biomechanics.

[11]  P. Libby,et al.  Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. , 1994, The Journal of clinical investigation.

[12]  E. Falk Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. , 1983, British heart journal.

[13]  M. Davies,et al.  Atherosclerotic plaque caps are locally weakened when macrophages density is increased. , 1991, Atherosclerosis.

[14]  P. Libby,et al.  Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme. , 1995, The American journal of pathology.

[15]  R D Kamm,et al.  Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels. , 1992, Circulation research.

[16]  P. Chambon,et al.  Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Isner,et al.  Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina. , 1995, Circulation.

[18]  P. Libby,et al.  Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[19]  J. Woessner,et al.  Matrix metalloproteinases and their inhibitors in connective tissue remodeling , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  A. Becker,et al.  Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. , 1994, Circulation.

[21]  M A Schork,et al.  Type I collagen gene expression in human atherosclerosis. Localization to specific plaque regions. , 1993, The American journal of pathology.

[22]  G. Liau,et al.  Regulation of extracellular matrix RNA levels in cultured smooth muscle cells. Relationship to cellular quiescence. , 1989, The Journal of biological chemistry.

[23]  P. Libby,et al.  Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. Henney,et al.  Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[25]  P. Macfarlane,et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia , 1995 .

[26]  M. Leon,et al.  Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. , 1995, The American journal of pathology.

[27]  M. Davies,et al.  Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. , 1993, British heart journal.

[28]  P. Constantinides Plaque Hemorrhages, Their Genesis and Their Role in Supra-Plaque Thrombosis and Atherogenesis , 1990 .

[29]  M. Ferguson,et al.  Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. , 1995, Circulation.

[30]  R. Kamm,et al.  Distribution of Circumferential Stress in Ruptured and Stable Atherosclerotic Lesions A Structural Analysis With Histopathological Correlation , 1993, Circulation.